Platform
Features
Pricing
0 followers
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Employees
Links
Nickolay V. Kukekov
0 members
TerrAscend
1 follower
Bayer
201 followers
Novartis
225 followers
Viatris
33 followers
Apellis Pharmaceuticals
7 followers
Charlie Health
5 followers
Ceva
4 followers
SmithRx
Roche
237 followers
Alembic Pharmaceuticals Ltd
3 followers
CAI
2 followers
Explore companies